Difference between revisions of "Infectious Pustular Vulvovaginitis"
Jump to navigation
Jump to search
m (Text replace - "Category:To_Do_-_Viruses" to "Category:To_Do_-_Clinical/Viruses") |
|||
| Line 21: | Line 21: | ||
***gE deletion makes this a '''marker vaccine''' | ***gE deletion makes this a '''marker vaccine''' | ||
***ELISA for gE deletion can enable culling of carrier animals | ***ELISA for gE deletion can enable culling of carrier animals | ||
| − | *IPV has mostly been made obsolete by AI[[Category:Cattle]] | + | *IPV has mostly been made obsolete by AI |
| + | |||
| + | |||
| + | [[Category:Reproductive Diseases - Cattle]] | ||
[[Category:To_Do_-_Clinical/Viruses]] | [[Category:To_Do_-_Clinical/Viruses]] | ||
Revision as of 11:40, 17 January 2011
Also known as IPV Caused by:Bovine Herpesvirus 1
- venereal transfer
Pathogenesis
- Painful genital lesions
- Impaired reproductive performance
- Frequent micturition
Diagnosis
- Virus isolation and immunofluorescence
Control
- Vaccination:
- Two live attenuated vaccines are available in the UK, one is temperature-sensitive
- Both given intranasally
- Neither protect against re-infection when given during clinical outbreak, but can lessen the severity of the disease
- Inactivated vaccines: intranasal/intramuscular administration
- gE deletion makes this a marker vaccine
- ELISA for gE deletion can enable culling of carrier animals
- Two live attenuated vaccines are available in the UK, one is temperature-sensitive
- IPV has mostly been made obsolete by AI